Expression of NaPi-IIb in rodent and human kidney and upregulation in a model of chronic kidney disease by Motta, Sarah E et al.








Expression of NaPi-IIb in rodent and human kidney and upregulation in a
model of chronic kidney disease
Motta, Sarah E ; Imenez Silva, Pedro Henrique ; Daryadel, Arezoo ; Haykir, Betül ; Pastor-Arroyo, Eva
Maria ; Bettoni, Carla ; Hernando, Nati ; Wagner, Carsten A
Abstract: Na+-coupled phosphate cotransporters from the SLC34 and SLC20 families of solute carri-
ers mediate transepithelial transport of inorganic phosphate (Pi). NaPi-IIa/Slc34a1, NaPi-IIc/Slc34a3,
and Pit-2/Slc20a2 are all expressed at the apical membrane of renal proximal tubules and therefore
contribute to renal Pi reabsorption. Unlike NaPi-IIa and NaPi-IIc, which are rather kidney-specific,
NaPi-IIb/Slc34a2 is expressed in several epithelial tissues, including the intestine, lung, testis, and mam-
mary glands. Recently, the expression of NaPi-IIb was also reported in kidneys from rats fed on high Pi.
Here, we systematically quantified the mRNA expression of SLC34 and SLC20 cotransporters in kidneys
from mice, rats, and humans. In all three species, NaPi-IIa mRNA was by far the most abundant renal
transcript. Low and comparable mRNA levels of the other four transporters, including NaPi-IIb, were
detected in kidneys from rodents and humans. In mice, the renal expression of NaPi-IIa transcripts was
restricted to the cortex, whereas NaPi-IIb mRNA was observed in medullary segments. Consistently,
NaPi-IIb protein colocalized with uromodulin at the luminal membrane of thick ascending limbs of the
loop of Henle segments. The abundance of NaPi-IIb transcripts in kidneys from mice was neither af-
fected by dietary Pi, the absence of renal NaPi-IIc, nor the depletion of intestinal NaPi-IIb. In contrast,
it was highly upregulated in a model of oxalate-induced kidney disease where all other SLC34 phosphate
transporters were downregulated. Thus, NaPi-IIb may contribute to renal phosphate reabsorption, and
its upregulation in kidney disease might promote hyperphosphatemia.
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Na+-coupled phosphate cotransporters from the SLC34 and SLC20 families of solute carriers mediate 
transepithelial transport of inorganic phosphate (Pi). NaPi-IIa/Slc34a1, NaPi-IIc/Slc34a3 and Pit-
2/Slc20a2 are all expressed at the apical membrane of renal proximal tubules, and therefore contribute 
to renal Pi reabsorption. Unlike NaPi-IIa and NaPi-IIc, which are rather kidney-specific, NaPi-IIb/Slc34a2 
is expressed in several epithelial tissues, including intestine, lung, testis and mammary glands. 
Recently, the expression of NaPi-IIb was also reported in kidneys from rats fed on high Pi. 
 
Here, we systematically quantified the mRNA expression of SLC34 and SLC20 cotransporters in kidneys 
from mice, rats and humans. In all three species, NaPi-IIa mRNA was by far the most abundant renal 
transcript. Low and comparable mRNA levels of the other four transporters, including NaPi-IIb, were 
detected in kidneys from rodents and humans. In mice, the renal expression of NaPi-IIa transcripts was 
restricted to the cortex whereas NaPi-IIb mRNA was observed in medullary segments. Consistently, 
NaPi-IIb protein colocalized with uromodulin at the luminal membrane of thick ascending limbs of the 
loop of Henle segments. The abundance of NaPi-IIb transcripts in kidneys from mice was neither 
affected by dietary Pi, the absence of renal NaPi-IIc, nor the depletion of intestinal NaPi-IIb. . In 
contrast, it was highly upregulated in a model of oxalate-induced kidney disease where all other SLC34 
phosphate transporters were downregulated. Thus, NaPi-IIb may contribute to renal phosphate 













Transport of inorganic phosphate (Pi) across the apical membrane of mammalian epithelial cells is 
mediated by Na+-coupled Pi cotransporters from the Slc34 and Slc20 families of solute carriers (for 
review see [21,5,72]). Both families use the electrochemical gradient of Na+ as driving force for the 
uphill transport of Pi, but whereas Slc34 proteins couple the uptake of one divalent Pi to the transport 
of either 2 or 3 Na+ ions, the Slc20 orthologues transport one monovalent Pi together with 2 Na+ ions 
[20]. The three members of the Slc34 family (Slc34a1/NaPi-IIa, Slc34a2/NaPi-IIb and Slc34a3/NaPi-IIc) 
have an overall peptide identity of about 50% that increases to roughly 80% in the predicted 
transmembrane domains. The two Slc20 proteins (Slc20a1/Pit-1 and Slc20a2/Pit-2) are also highly 
conserved (overall identity of 60%). However, the homology between Slc34 and Slc20 members is no 
higher than 10%.  
 
Renal reabsorption of Pi takes place along the proximal tubules, with early studies providing 
contradictory data regarding a potential contribution of distal parts of the nephron [1,67,11,39,31,24]. 
NaPi-IIa, NaPi-IIc and Pit-2 are expressed at the brush border membrane (BBM) of proximal tubular 
cells, and their abundance is regulated by several hormones, including parathyroid hormone (PTH), 
fibroblast growth factor 23 (FGF23) and dopamine, as well as by dietary Pi. Low dietary Pi upregulates 
the expression of the three renal cotransporters, which consequently increases Pi reabsorption and 
reduces urinary excretion of Pi [42,71,10]. Instead high dietary Pi [71,10,42], PTH [53,36,52,65,16,18], 
FGF-23 [63,66,14,38,70] and dopamine [2,16] reduce their expression and, therefore, have a 
phosphaturic effect. In mice, ablation of NaPi-IIa results in hypophosphatemia due to urinary loss of 
Pi, despite a two-fold increase in NaPi-IIc abundance [3]. In contrast, the absence of NaPi-IIc does not 
disturb Pi homeostasis [64,48]. However, mutations in both SLC34A1/NaPi-IIa [55,60,19] and 
SLC34A3/NaPi-IIc [4,29,41] have been identified in patients with renal loss of phosphate and 
hypophosphatemia demonstrating that both transporters are critical in humans (for review see 
[73,40]).  
 
Intestinal absorption of Pi is proposed to involve both passive/paracellular and active/transcellular 
mechanisms. NaPi-IIb, Pit-1 and Pit-2 are expressed among other tissues in intestinal epithelia (for 
review see [27]), though whether or not they are the only active intestinal transporters remains an 
open issue [12]. The relative abundance of NaPi-IIb along the different intestinal segments seems to 
be species-specific. In mice, this transporter is mostly found in the ileum [54], whereas in rats [22,44] 
it is preferentially expressed in duodenum and jejunum. A higher contribution to intestinal Pi 
absorption of jejunum than ileum was also suggested in humans [33,74]. Studies in Slc34a2 knockout 
mice indicate that NaPi-IIb is responsible for more than 90% of the active Pi absorption by the small 
intestine though its overall contribution to intestinal absorption is not bigger than 50% [26,58]. The 
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pattern of expression of Pit transporters along the gut is also different in rats [22,12] and mice (Pastor-
Arroyo, unpublished data). Dietary Pi also controls the abundance of intestinal cotransporters, with 
high and low dietary Pi inducing their downregulation and upregulation, respectively 
[13,22,25,62,54,34].  The expression of NaPi-IIb in the intestinal epithelia is stimulated by 1,25 (OH)2 
vitamin D3 [25,76,45].  
 
In addition to kidney and/or intestine, Pit-1, Pit-2 and NaPi-IIb are widely expressed. High levels of Pit-
2 are found in the brain [30], where the transporter may be involved in controlling Pi in the 
cerebrospinal fluid. Mutations in Pit-2 are one of the causes of familial idiopathic basal ganglia 
calcification (FIBGC) [75], a disease recapitulated in Pit-2 deficient mice [32]. Both Slc20 transporters 
were recently proposed to contribute to extracellular Pi sensing [7,8]. Expression of NaPi-IIb mRNA has 
been reported in several organs including lungs, mammary glands, liver and testis [28]. Although very 
little is known about its role in these tissues, mutations in NaPi-IIb cause pulmonary alveolar 
microlithiasis (PAM) and may as well associate with testicular microlithiasis [15,59,69]. Indeed, the 
concentration of Pi in the bronchoalveolar fluid is markedly elevated in NaPi-IIb-/- mice [59]. Expression 
of NaPi-IIb mRNA was also reportedin kidneys of rats fed high Pi [68]. This study reported the expected 
reduction of NaPi-IIa and NaPi-IIc abundance in kidneys upon high dietary Pi, whereas the renal mRNA 
expression of NaPi-IIb was increased in the high Pi fed animals. Surprisingly, a basolateral localization 
of NaPi-IIb in unidentified nephron segments was reported using an antibody not well validated. 
 
The aims of this work were to compare the expression of NaPi-IIb/SLC34A2 to the other members of 
the SLC34 and SLC20 families in kidneys from mice, rats and humans, to identify the tubular segments 
expressing NaPi-IIb and to investigate potential physiological/pathophysiological conditions able to 
regulate its renal expression. For the last aim, the abundance of NaPi-IIb transcripts was compared in 
samples from wild type (WT) mice and in several models deficient for particular Slc34 cotransporters, 









Material and Methods 
 
Animals All experiments described below were approved by the local veterinary authority (Kantonales 
Veterinäramt Zürich) and complied with Swiss Animal Welfare laws. 
 
Mice Experiments were performed with  10-14 weeks WT male mice (C57BL/6J, Janvier, France) as 
well as with mice with constitutive and global depletion of NaPi-IIa (NaPi-IIa -/-) [3], intestinal-specific 
depletion of NaPi-IIb (NaPi-IIb-/-) [26] and renal specific and inducible depletion of NaPi-IIc (NaPi-IIc-/-) 
[48]. For NaPi-IIa-/- and NaPi-IIb-/-, WT littermates were used as control, whereas the values of NaPi-IIc-
/- (floxed/floxed animals drinking doxycycline) were compared with floxed/floxed mice drinking 
sucrose. For collection of blood and/or organs mice were anesthetized with 2% isoflurane; samples 
were snap frozen until further use. 
 
Comparison between genotypes. All animals were fed standard chow (KLIBA: 0.8% Pi, 1% Ca2+ and 1000 
IU/kg vitamin D3), and each group consisted of 5 mice. 
 
Dietary adaptation in WT mice. Mice were fed either a standard diet (KLIBA: as above) or diets with 
low (KLIBA: 0.1% Pi, 1% Ca2+ and 1000 IU/kg vitamin D3) or high (KLIBA: 1.2% Pi, 1% Ca2+ and 1000 IU/kg 
vitamin D3) Pi content. High and low Pi diets were administered both acutely (18 and 24 hours) and 
chronically (3 and 5 days). Each dietary group consisted of 5 mice. 
 
Oxalate treatment of WT mice. Mice (male, 12 weeks old) were first adapted for 3 days to a low Ca2+-
containing chow (Ssniff: 0.4 Pi and 2200 IU/kg vitamin D3, no Ca2+ added) followed by 4 days 
administration of a low Ca2+ high oxalate diet (Ssniff: 0.4 Pi and 2200 IU/kg vitamin D3 and 6.7 g sodium 
oxalate/kg, no Ca2+ added), or 4 days low Ca2+-containing chow as a control group. Then, they were left 
to recover for 4 days on standard chow (KLIBA). On the last day, mice were placed in metabolic cages 
for collection of 24 hours urine. Blood and kidneys were collected under anesthesia. Each dietary group 
consisted of 6 mice. 
 
Rats Male Wistar rats were purchased from Charles River (Germany). Experiments were performed on 
6 to 8 weeks old rats fed standard diet. For collection of kidneys and intestines, rats were anesthetized 
with 3% isoflurane; samples were snap frozen until further use. 
 
Human kidneys Non-transplantable human kidneys were obtained from the International Institute for 
Advancement of Medicine (IIAM; Edison-NJ. USA), with the approval of the local ethics committee. 
Samples were derived from 2 female and 3 male donors, with an age between 50 and 63 years. Their 
blood urea nitrogen values ranged between 16 to 39 mg/dL (mean ± SEM: 29.4 ± 5) and their plasma 




RNA isolation and semi-quantitative Real-Time PCR (qPCR) RNA was isolated from kidney and 
intestinal samples using the Qiagen RNeasy Mini extraction kit (Qiagen, Germany). Isolation was done 
according to the instructions provided by the manufacturer. Purified RNA was then transcribed to 
cDNA (TaqMan Reverse Transcription Kit, Applied Biosystems) which was later used as template for 
the PCR. The relative expression of the genes of interest was quantified by using sequence-specific 
forward and reverse primers together with sequence-specific probes labeled with reporter (5’-end, 
FAM), and quencher (3’-end, TAMRA) dyes. Custom-designed primers and probes were synthetized by 
Microsynth (Balgach, Switzerland) whereas commercially-available sets were purchased from Applied 
Biosystems (supplementary table 1). Hypoxanthine-guanine phospho-ribosyltransferase (HPRT) or 18S 
were used as housekeeping genes, and their probes were labeled with VIC as reporter dye. qPCR was 
performed using the 7500 Fast Real Time PCR System, and the obtained data was analyzed with the 
7500 Fast Real-Time PCR System Sequence Detection Software v1.4. Ct values were calculated after 
adjusting the baseline threshold to 0.06. The relative fold change was calculated according to the 
formula 2(Ct (control) - Ct (experiment)). 
 
In Situ Hydridization Mice were anesthetized with isoflurane, pre-perfused with heparin and perfused 
with fixative (3% PFA in 0.1 M Na-cacodylate) through the left cardiac ventricle. Kidneys were 
harvested and processed for embedding (O.C.T. embedding matrix, Cell Path) as previously reported 
[53]. Embedded and frozen kidneys were stored at -80 °C until further use. Renal sections (5 μm thick) 
were prepared with a cryotome (Leica Biosystems), and immediately mounted on slides (Superfrost 
Plus, Thermo Scientific). Renal sections were processed for in situ hybridization using the RNAscope 
2.5HD Duplex assay as well as the RNAscope 2.5 chromogenic assay (both from Bio-techne) following 
the manufacturer’s recommendations. Briefly, samples were first rehydrated in PBS and then boiled 
for 5 minutes in a target retrieval solution provided by the kit. Afterward, tissue samples were 
hybridized for 2 hours at 40°C with NaPi-IIa/Slc34a1 and/or NaPi-IIb/Slc34a2 mRNA probes, subjected 
to signal amplification and incubated with fluorescent or alkaline phosphatase-labelled probes. For the 
chromogenic assay, samples were then incubated for 10 min at room temperature with Fast Red 
substrate and counterstaining with Gill’s Hematoxylin I. All samples were finally mounted with 
VectaMount Mounting Medium HT-5000 (Vector Laboratories, Burlingame, CA, USA). Signals were 
analyzed with a microscope (Leica DM 55008). As negative and positive controls, additional tissue 
samples were processed in parallel with probes for the bacterial dihydrodipicolinate reductase (DapB) 
and the mouse peptidyl-prolyl cis-trans isomerase B (Ppib), respectively.  
 
Western Blot Renal and intestinal BBM were prepared according to the Mg2+ precipitation technique 
[6]. BBM were resuspended in 300 mM Mannitol, 20 mM Hepes-Tris, pH 7.4 and stored at -20 °C. 
Proteins (25-50 μg of BBM or 75 μg of homogenates) were separated by electrophoresis in 10% SDS-
polyacrylamide gels and transferred to PVDF membranes. Membranes were incubated overnight at 
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4 °C with NaPi-IIb [28] primary antibody (dilution 1: 3,000) followed by 2 hours incubation at room 
temperature with secondary antibody (anti-rabbit HRP-conjugated IgG diluted 1: 5,000). For the 
detection of actin, a monoclonal antibody raised in mouse was applied (SIGMA Aldrich, dilution 1: 
5,000), using as secondary antibody anti-mouse HRP-conjugated IgG (dilution 1: 10,000). Primary and 
secondary antibodies were diluted in TBS containing 5% powder milk. All secondary antibodies were 
purchase from GE Healthcare. After addition of chemiluminescent HRP substrate (Millipore; CDP-star, 
Roche), chemiluminescence was detected with a LAS-4000 Fujifilm image analyzer. For peptide 
protection, the antigenic peptide used to raise the NaPi-IIb antibody [28] was incubated for 2 hours at 
room temperature with the NaPi-IIb antisera (75-100 μg peptide/ml diluted antibody) prior to addition 
of the antisera to the PVDF membrane. 
 
Immunofluorescence Mouse renal sections (5 μm thick) prepared as indicated above were first 
subjected to antigen retrieval. For that, samples were microwaved for 5 minutes in 10 mM citrate 
buffer at pH 6.0, followed by incubation in 1% SDS/PBS for 5 minutes at room temperature. After three 
washes in PBS, non-specific protein binding was prevented by treatment with blocking solution (1% 
BSA/PBS) for 15 minutes at room temperature. Cryosections were then incubated overnight in a 
humidified chamber at 4°C with the following primary antibodies diluted in PBS: sheep anti- 
Uromodulin (1: 500, Thermo Fisher Scientific, PA5-47706), rabbit anti-NaPi-IIa (1: 2,000 [17]), rabbit 
anti-NaPi-IIb (1: 1,000 [28]), or rabbit anti-NaPi-IIc (1: 500 [50]). Upon removal of primary antibodies, 
sections were rinsed three times with PBS and once with hypertonic PBS (18 g NaCl/l PBS) and then 
incubated for 1 hour at room temperature in the dark with the appropriate secondary antibodies: 
donkey anti-rabbit Alexa Fluor-594 (1: 500; Life Technologies, A21207) and donkey anti-sheep DyLight-
488 (1: 500; Abcam, ab96939).  Nuclei were stained by addition of 4ʹ, 6-diamidino-2-phenylindole 
dihydrochloride (DAPI) (1: 500, Sigma, D9542) to the secondary antibody solution. Thereafter, slides 
were washed twice with hypertonic PBS and once with PBS before being covered with mounting 
medium (Dako, USA) and coverslips. Slides were viewed using a Leica DM 5500B fluorescence 
microscope and processed using Adobe Photoshop (Adobe Photoshop, San Jose, CA). Sections of 
mouse ileum were also subjected to 1% SDS antigen retrieval; then samples were incubated with the 
NaPi-IIb antibody (1:200) together with DAPI (1:1,000) and phalloidin texas red (1:100). For peptide 
protection, the NaPi-IIb antibody was pre-incubated with antigenic peptide (100 μg peptide/ml diluted 
antibody) as indicated above. 
 
Determination of urinary and plasma metabolites Urinary and/or plasma levels of creatinine, urea 
and Pi were measured with a UniCel DxC 800 Synchron Clinical System in the Zurich Integrative Rodent 




Presentation and statistical analysis Data are presented as mean ± SEM. Statistical significance was 
determined by ANOVA or t-test and P < 0.05 was considered as significant. 
 
Results   
 
NaPi-IIa is the Na/Pi cotransporter with higher renal mRNA expression in mice, rats and humans 
 
The mRNA expression of the three members of the Slc34 family of Na/Pi-cotransporters (NaPi-IIa, NaPi-
IIb and NaPi-IIc) together with the two members of the Slc20 family (PiTt-1 and Pit-2) was analyzed by 
qPCR in kidneys of mice and rats and human. To verify that the sets of primers/probe used to quantify 
each of the five transcripts did actually have similar amplification efficiencies, PCRs were performed 
using as template progressive cDNA dilutions. Then, a standard curve was constructed by plotting the 
Ct values against the cDNA concentrations. The efficiency of each set of primers/probe was calculated 
from the formula 10(-1/slope), with a maximal efficiency having a value of 2. As shown in supplementary 
table 1, for all three species, the amplification efficiency of the five cotransporters mRNAs was found 
to be very similar, and close to the maximal value. Based on these data, the comparison of different 
mRNAs abundances is indeed feasible. 
 
In kidneys from mice (Fig. 1A) and rats (Fig. 1B), NaPi-IIa showed by far the highest level of mRNA 
expression. Although transcripts of all the other cotransporters were also detected, their abundance 
was about two orders of magnitude smaller than the values detected for NaPi-IIa. Moreover, no major 
differences were found for the renal mRNA expression of these four cotransporters. Similar to both 
murine models, cortical preparations from human kidneys express much higher levels of NaPi-IIa 
mRNA than of the other four genes (Fig. 1C). Interestingly, in the three analyzed species the relative 
expression of NaPi-IIb mRNA was comparable to the abundance of NaPi-IIc transcripts.  
 
NaPi-IIa and NaPi-IIb are expressed in different and distinct nephron segments in mouse kidney  
 
The pattern of expression of NaPi-IIa and NaPi-IIb transcripts in murine kidneys was next compared by 
in situ hybridization (RNAscope) (Fig. 2A). Analysis of renal slices incubated simultaneously with 
fluorescent probes for NaPi-IIa (red) and NaPi-IIb (green) indicated that NaPi-IIa mRNA is highly 
abundant in a cortical population of tubules morphologically identified as proximal tubules, whereas 
no signal was detected in the medulla. Although far less abundant than NaPi-IIa, a clear signal was also 
observed with the NaPi-IIb probe (Fig. 2A), confirming the expression of this transporter mRNA in 
kidney. Tubules positive for NaPi-IIb mRNA were mostly located in the outer medulla, such that no 
overlapping of both cotransporters was observed. Expression of NaPi-IIb transcripts in medullary 
segments was further confirmed using a chromogenic in situ hybridization probe: as shown in Fig. 2B, 
the NaPi-IIb chromogenic probe provided a stronger signal than the fluorescence probe. No signal was 
9 
 
observed in sections incubated with a probe for the bacterial dihydrodipicolinate reductase (data not 
shown). The segments expressing NaPi-IIb mRNA were likely thick ascending limbs (TAL) of the loop of 
Henle. This was further supported by the analysis of published data from two different databases 
reporting single cell transcriptome data from mouse kidney [51,56] (see supplementary figure 4). Data 
from Park et al. showed high abundance of NaPi-IIa mRNA in all nephron segments with a strong peak 
in proximal tubule. NaPi-IIc mRNA was also localized to proximal tubule, whereas NaPi-IIb transcripts 
were mostly found in TAL of the loop of Henle [51]. A more detailed analysis of the male and female 
murine kidney reported by Ransick et al, demonstrates selective expression of NaPi-IIa and NaPi-IIc 
mRNA in the proximal tubule of both male and female kidneys. In both genders, NaPi-IIb mRNA is 
restricted to the thin descending and ascending limbs of the loop of Henle as well as the TAL [56].  
 
The renal presence of NaPi-IIb at the protein level was then analyzed by immunofluorescence and its 
pattern of expression compared with that of NaPi-IIa and NaPi-IIc. As expected, the expression of NaPi-
IIa and NaPi-IIc was restricted to the BBM of renal proximal tubules (Fig. 3A, C), and none of them 
colocalized with uromodulin. In agreement with the in situ hybridization data, incubation with a NaPi-
IIb antibody labeled the luminal side of a small population of medullary tubules, mostly located in the 
outer medulla, that were also positive for uromodulin (Fig. 3B). The specificity of the NaPi-IIb antibody 
was demonstrated by peptide protection of immunostainings of ileum sections as well as of 
Westernblot of ileum homogenates (supplementary Fig. 1): in both cases the NaPi-IIb-related signal 
was abrogated upon preincubation of the antibody with the immunogenic peptide consistent with the 
absence of signal in intestine-specific NaPi-IIb KO mice using the same antibody [26]. Although 
Westernblots detected a faint band at the expected size in protein samples from mouse kidney, this 
signal is most probably unspecific, as its intensity was not reduced upon peptide protection 
(supplementary Fig. 1E, F). Furthermore, no band corresponding to NaPi-IIb was detected in kidneys 
from mice fed acutely (1 day) or chronically (5 days) with high or low Pi diets (data not shown). 
 
NaPi-IIb is the Na/Pi cotransporter with higher mRNA expression in mouse ileum and rat jejunum 
 
The expression of Slc34 and Slc20 cotransporters was also compared in intestinal segments, namely 
ileum from mice and duodenum and jejunum from rats (supplementary Fig. 2). These segments were 
selected based on available data showing that in mice active intestinal transport of Pi proceeds mostly 
along the ileum [54], whereas duodenum and jejunum are the segments responsible for active 
intestinal absorption in rats [22,44]. In ileum from mice, the expression of NaPi-IIb mRNA was between 
3 orders (vs. Pi1-1 and Pit-2) to 4 orders (vs. NaPi-IIa and NaPi-IIc) of magnitude higher than the 
expression of the other cotransporters (supplementary Fig. 2A), consistent with the major role of NaPi-
IIb in active intestinal absorption of Pi suggested in recent publications [26,58]. Also in rat duodenum, 
the expression of NaPi-IIb transcripts was far higher than that of other transporters (supplementary 
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Fig. 2B). Instead, similar expression of NaPi-IIb and Pit-1 mRNAs was detected in rat jejunum 
(supplementary Fig. 2C), whereas the expression of the other cotransporters was between one order 
(vs. Pit-2) to 3 orders (vs. NaPi-IIa and NaPi-IIc) of magnitude lower. 
 
Renal expression of Na/Pi cotransporters mRNAs in mice is not altered by dietary phosphate or by 
the absence of Slc34 paralogues 
 
The renal abundance of Slc34 and Slc20 transcripts was compared in kidney samples from wild type 
mice fed acutely (18 and 24 hours) and chronically (3 and 5 days) with diets containing either low 
(0.1%) or high (1.2%) Pi. As shown in Fig 4, the expression of the analyzed cotransporters was altered 
neither after 18 hours (A) nor after 5 days (B), except for small changes in Pit-2 and NaPi-IIc expression 
in the acute and chronic diets, respectively. Comparable mRNA levels were also found in samples from 
mice fed 24 hours or 3 days with either high or low Pi diets, except for a small downregulation of NaPi-
IIc expression in mice fed 3 days on high Pi (data not shown). 
 
The renal mRNA expression of all Slc34 and Slc20 cotransporters was also compared in mouse models 
deficient for Slc34 members either in kidney (NaPi-IIa and NaPi-IIc) or in intestine (NaPi-IIb). Neither 
the absence of renal NaPi-IIa (Fig. 5A) or renal NaPi-IIc (Fig. 5C) not depletion of intestinal NaPi-IIb (Fig. 
5B) resulted in major changes in the renal expression of the remaining cotransporters, with only a small 
upregulation of NaPi-IIb expression in NaPi-IIa deficient mice.   
 
Renal expression of Na/Pi cotransporters mRNAs is differentially altered in mice with oxalate-
induced nephropathy 
 
Feeding mice for 4 days with a high oxalate diet resulted in elevated plasma levels of creatinine and 
urea (supplementary Fig. 3) as well as in reduced creatinine clearance (Fig. 6A) as reported earlier for 
this model of oxalate nephropathy [46]. Furthermore, urinary excretion of Pi tended to be reduced 
(Fig. 6B) whereas plasma Pi was increased (Fig. 6C). The circulating concentration of intact FGF-23 (Fig. 
6D), as well as the renal mRNA levels of Ffg23 (Fig. 6E) and tumor necrosis factor (Tnf) (Fig. 6F) were 
all higher in oxalate-treated mice. 
 
Oxalate treatment decreased the renal expression of NaPi-IIa and NaPi-IIc transcripts whereas it 









The Slc34 and Slc20 families of Na+/Pi cotransporters mediate the first step of transcellular transport 
of Pi across the apical membrane of epithelial cells. NaPi-IIa/Slc34a1 and NaPi-IIc/Slc34a3 are 
considered to be the major Na+/Pi cotransporters responsible for the reabsorption of filtered Pi from 
the primary urine. Here, we report that NaPi-IIa shows by far the highest level of mRNA expression in 
kidneys from adult mice, rats and humans. This finding is in agreement with the major and 
unreplaceable role of the cotransporter in mice [3] as well as with its implication in the development 
of idiopathic infantile hypercalcemia (OMIM #616963) in humans (for review see [73]). In contrast, the 
expression of NaPi-IIc transcripts in all three species was one (rats) to two (mice, humans) orders of 
magnitude lower than those detected for NaPi-IIa. The relative low expression of NaPi-IIc mRNA in 
both murine models is in accordance with current literature. Its low expression in adult rats was 
suggested by antisense hybrid depletion experiments in which depletion of NaPi-IIc mRNA from renal 
poly(A)+ RNA extracted from young rats was shown to reduce the capacity of the RNA pool to induce 
Pi-transport in oocytes, whereas depletion from adult samples had no effect [61]. On the other hand, 
NaPi-IIc ablated mice have an unperturbed Pi homeostasis, suggesting a minor contribution to renal Pi 
handing in mice [26,64]. Based on the above observations, it is currently accepted that in rodents NaPi-
IIc is a juvenile transporter and that its contribution to Pi balance in adults is negligible [61]. However, 
its low expression level in kidneys from adult humans was unexpected, since it is well established that 
mutations in NaPi-IIc in humans cause hereditary hypophosphatemic rickets with hypercalciuria, with 
persistent symptoms in adult patients (HHRH; OMIM #241530) (for review see [73]). This apparent 
discrepancy could be either related to the specific pathological state of the donors, to a lack of 
correlation between RNA and protein levels, or to a decline on the expression of the cotransporter 
with age in humans, in a similar way to mice. Interestingly, we could detect renal expression of NaPi-
IIb transcripts in all three species analyzed; furthermore, in all cases its abundance was comparable to 
the levels of NaPi-IIc (and Slc20) mRNAs. Relatively small but consistent mRNA expression of NaPi-IIb 
in mouse and human kidneys was already reported by Hilfiker et al and Nishimura and Naito, 
respectively [28,49]. 
 
As expected, we found that NaPi-IIa mRNA is highly abundant in the cortex and absent from medulla. 
The cortical  expression of NaPi-IIa is in agreement with early reports in which using different 
techniques (in situ hybridization with radioactive probes, and qPCR on RNA extracted from isolated 
nephron segments) the expression of NaPi-IIa transcripts was shown to be restricted to proximal 
tubules [43,57]. In a recently published transcriptome study Ransick et al. reported single-cell RNA 
sequencing of adult male and female mouse kidneys [56] (supplementary Fig. 4A). For the analysis, 
cortical and juxtamedullary nephrons as well as ureteric epithelium were subdivided in up to 32 
anatomically and functionally distinct regions, from podocytes to deep medullary epithelium of pelvis 
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(for details see legend to supplementary Fig. 4). As expected, this study confirmed the presence of 
NaPi-IIa mRNA specifically in the S1 and S2 segments of proximal tubules of both cortical and 
juxtamedullary nephrons. Furthermore, it also reports the expression of NaPi-IIc transcripts in S1 
segments of both populations of nephrons, though in agreement with our data, its relative abundance 
is much lower than that of NaPi-IIa. More importantly, it also describes the presence of NaPi-IIb mRNA 
in the thin descending and ascending limbs of the loop of Henle as well as the TAL. This pattern of 
expression confirms our own findings and implies that, due to the anatomical differences between 
both populations, transcription of NaPi-IIb mRNAs is restricted to juxtamedullary nephrons, whereas 
no signal is detected in cortical nephrons [56]. Ransick et al. describe expression levels of NaPi-IIb even 
lower than those of NaPi-IIc. Surprisingly, a second transcriptome analysis of mouse kidney single cells 
published recently by Park et al. describes the presence of NaPi-IIa mRNA not only in proximal tubules 
but also in a large percentage of  podocytes as well as of cells of the loop of Henle, distal tubules and 
principal and intercalated cells [51] (supplementary Fig. 4B), possibly reflecting contamination of cells 
from these segments with the highly abundant NaPi-IIa transcript during preparation of single cells. 
However, in agreement with Ransick’s report and with the data presented here, Park et al. show that 
expression of NaPi-IIb mRNA takes place specifically in the loop of Henle, whereas the proximal tubule 
is reported as the segment with larger number of cells expressing NaPi-IIc transcripts [51]. Moreover, 
the percentage of cells found to be positive for NaPi-IIb and NaPi-IIc transcripts is far lower than those 
positive for NaPi-IIa. 
 
Immunofluorescence analysis in mouse kidneys using antibodies against NaPi-IIa and NaPi-IIb 
corroborated their pattern of expression at the RNA level. For NaPi-IIa and NaPi-IIc our 
immunolocalization here is in agreement with previous publications demonstrating their overlapping 
localization in early parts of the proximal tubule, with higher expression in juxtamedullary nephrons in 
animals on a normal or low Pi diet  [17,53]. Moreover, we could demonstrate that while NaPi-IIa and 
NaPi-IIc do not colocalize with uromodulin, a urinary glycoprotein produced by the TAL of the loop of 
Henle, NaPi-IIb antibodies stained a small number of tubules also positive for uromodulin. In addition 
to confirming the TAL localization of NaPi-IIb, the sparse RNA and immunofluorescence signal of the 
cotransporter in renal tissue probably explains the failure of the antibody to detect the protein on 
Western blots. Of note, the NaPi-IIb orthologue from zebrafish is expressed at the apical membrane of 
renal and intestinal epithelia [23]. Our immunolocalization data is in contrast to a previous report 
where intracellular expression of NaPi-IIb at the protein level was described in kidneys from rats fed 
standard Pi, whereas in rats fed on high Pi the transporter was detected intracellularly or bound to the 
basolateral membrane [68]. This discrepancy may be related to the use of different antibodies. The 
specificity of the antibody used in our work was previously confirmed by peptide protection [28] and 
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by the lack of cross-reaction in intestinal samples from knockout mice [26], and validated here as well 
(supplementary Fig. 1), whereas a commercial antibody was used in the mentioned rat study.  
 
The presence of an active Pi transporter in nephron segments beyond proximal tubules was postulated 
decades ago. This hypothesis was based on micropuncture studies published by Amiel et al. in 1970 
showing that the delivery of Pi to superficial distal tubules in rats is higher than the concentration in 
ureteral urine, suggesting reabsorption of Pi by distal segments of the nephron [1]. Furthermore, this 
study postulated that distal transport was active and inhibited by PTH. In 1997 Greger et al. also 
reported higher delivery of Pi to superficial distal tubules than urinary excretion of Pi, though the 
authors failed to detect 32P reabsorption by the terminal segments of the rat nephron [24]. However, 
they could detect reabsorption of Pi in the loop of Henle of thyroparathyroidectomized (TPTX) rats, 
suggesting that the transporter was sensitive to PTH. Also using micropuncture techniques, Jaeger et 
al. reported in 1983 that intravenous administration of potassium to rats increases the Pi-reabsorbing 
capacity of the distal tubule, though they could not detect distal reabsorption in control  rats [31]. 
However, in this study the effect of potassium was abrogated in thyro-parathyroidectomized animals 
suggesting a mechanism different from those described above. In contrast to these reports, other 
investigators failed to detect distal transport of Pi [11,67], attributing the previous observations to 
nephron heterogeneity, since proximal tubules of cortical nephrons (the ones accessible to 
micropuncture) reabsorb Pi less avidly than proximal tubules of juxtamedullary nephrons. Whether or 
not NaPi-IIb could be implicated in this putative distal transport remains to be investigated. 
 
The mRNA expression of NaPi-IIb in kidney is not regulated neither by acute nor by chronic changes in 
dietary Pi. This is not surprising since most reports agree on the lack of effect of acute changes on 
dietary Pi on transcription of renal cotransporters [9,57,35], though there are contradictory reports 
regarding the effect of chronically provided diets [9,43]. Similarly, the renal abundance of NaPi-IIb 
transcripts is affected neither by the absence of NaPi-IIc in kidney nor by depletion of intestinal NaPi-
IIb, showing just a minor increase in NaPi-IIa deficient mice. Instead, we found that NaPi-IIb mRNA 
expression is highly upregulated in kidneys of mice with oxalate nephropathy, in contrast to NaPi-IIa 
and NaPi-IIc, which are downregulated. Oxalate feeding has been shown as a model of crystal 
nephropathy leading to chronic kidney disease in mice [37,46,47]. In our hands, oxalate treatment 
resulted in kidney damage, as indicated by the reduced creatinine clearance and tendency for reduced 
urinary excretion of Pi. Furthermore, treated mice showed the expected increase of both plasma 
phosphate and FGF-23 production (plasma levels and renal mRNA expression), and showed signs of 
inflammation (high renal Tnf mRNA levels). Increased expression and activity of NaPi-IIb in the setting 





In summary, we have shown that kidneys from mice, rats and humans express NaPi-IIb mRNA at levels 
comparable to those of NaPi-IIc. In mice, renal NaPi-IIb colocalizes at the protein level with uromodulin, 
but not with NaPi-IIa or NaPi-IIc. The expression of NaPi-IIb transcripts in kidneys from mice is not 
regulated by dietary Pi and it is not altered in several Slc34 deficient models, except for a small 
upregulation in NaPi-IIa deficient mice. However, while NaPi-IIa and NaPi-IIc mRNAs are 







Figure 1. Renal mRNA expression of Na/Pi cotransporters in kidneys: real-time PCR. Relative mRNA 
expression of NaPi-IIa, NaPi-IIb, NaPi-IIc, Pit-1 and Pit-2 in kidneys of A) mice (n=5) and B) rats (n=5) 
fed on standard chow as well as in C) cortical sections of human kidneys (n=5). Ct values of each mRNA 
were normalized to the Ct values of HPRT. 
 
Figure 2. Renal mRNA localization of Na/Pi cotransporters: in situ hybridization. A) Pattern of 
expression of NaPi-IIa (red) and NaPi-IIb (green) mRNAs in mouse kidney using fluorescently labelled 
in situ hybridization probes. Images on the left column show merged signals, whereas images on the 
middle and right columns show NaPi-IIa and NaPi-IIb mRNA signals individually. Images in the top row 
were taken in the renal cortex while the pictures in the middle and bottom rows were taken in medulla. 
B)  Pattern of expression of NaPi-IIb in mouse kidney using a chromogenic in situ hybridization probe. 
White bars represent 25 µm. 
 
Figure 3. Renal protein localization of Slc34 Na/Pi cotransporters. Kidney slices from mice were co-
stained with antibodies against uromodulin together with antibodies against either A) NaPi-IIa, B) 
NaPi-IIb or C) NaPi-IIc. The uromodulin-related signal is shown in green and the cotransporters 
expression in red. White bars represent 25 µm. 
 
Figure 4. Renal mRNA expression of Na/Pi cotransporters in wild type mice fed low or high Pi. 
Relative mRNA expression of NaPi-IIa, NaPi-IIb, NaPi-IIc and Pit-2 in kidneys of mice fed low (L) or high 
(H) Pi diets either A) acutely (18 hours; n=5) or B) chronically (5 days; n=5). Ct values of each mRNA 
were normalized to the Ct values of the control mRNA HPRT. * P< 0.05; unpaired t-test. 
 
Figure 5. Renal mRNA expression of Na/Pi cotransporters in wild type and Slc34 depleted mice. 
Relative mRNA expression of NaPi-IIa, NaPi-IIb, NaPi-IIc, Pit-1 and Pit-2 in kidneys of mice deficient for 
A) NaPi-IIa (n= 4), B) intestinal NaPi-IIb (n=8) or C) renal NaPi-IIc (n=8) and their respective wild type 
littermates (sample size similar to the KO group). Ct values of each mRNA were normalized to the Ct 
values of the control mRNA HPRT. ** P< 0.001; **** P< 0.0001; unpaired t-test. 
 
Figure 6. Effect of oxalate treatment of wild type mice. A) Creatinine clearance, B) urinary Pi, C) 
plasma Pi, D) plasma intact FGF-23, E) renal Fgf23 mRNA F) renal Tnf mRNA in wild type mice treated 
with a control (white bars) or oxalate-rich (back bars) diet. G) Renal mRNA expression of Slc34 and 
Slc20 Na/Pi cotransporters. Ct values of tested genes were normalized to the Ct values of 18S mRNA. 
n=6 for both groups in all determinations. ** p<0.01, *** p< 0.001. Student t-test 
 
Supplementary table 1 Sequence or source and efficiency of qPCR primers (Fw= forward; Rv= reverse) 
and probes used to quantify the expression of Slc20 and Slc34 cotransporters in samples from mice, 




Supplementary Figure 1. Validation of the anti NaPi-IIb antibody A-D) Immunofluorescence of mouse 
ileum with an anti-NaPi-IIb antibody (green) as well as with DAPI (blue) and phalloidin (red). A, B) signal 
in the absence of the antigenic peptide. C, D) signal in the presence of the antigenic peptide. E-F) 
Westernblots on kidney homogenates (K) and intestinal BBM (I) of mice using anti-NaPi-IIb (top panels) 
and actin (bottom panels) antibodies. Signals E) without or F) with antigenic peptide. The arrowhead 
indicates the position of the transporter in BBM isolated from ileum.  
 
Figure 2. Intestinal mRNA expression of Na/Pi cotransporters: real-time PCR. Relative mRNA 
expression of NaPi-IIa, NaPi-IIb, NaPi-IIc, Pit-1 and Pit-2 in A) ileum of WT mice (n=5) as well as B) 
duodenum and C) jejunum from rats (n=5). Expression of Pit-1 in rat duodenum was not tested. Ct 
values of each mRNA were normalized to the Ct values of the control mRNA HPRT. 
 
Supplementary Figure 3. Effect of oxalate treatment on wild type mice A) Plasma creatinine, and B) 
plasma urea. n=6. ** p<0.01, *** p< 0.001. Student t-test 
 
Supplementary Figure 4. Data from single cell transcriptome analysis from mouse kidneys A) 
Expression of NaPi-IIa, NaPi-IIb and NaPi-IIc mRNAs in juxtamedullary nephrons and ureteric 
epithelium. Scheme taken from Ransick et al; Developmental Cell, 2019. Average expressions are given 
in logarithmic scale. Subdivisions indicate: 1) podocytes (visceral epithelium), 2) parietal epithelium, 3) 
segment 1 of proximal tubule – female, 4) segment 1 of proximal tubule – male, 5) segment 2 of 
proximal tubule –female, 6) segment 2 of proximal tubule – male, 7) segment 3 of proximal tubule – 
female, 8) segment 3 of proximal tubule – male, 9A) LOH thin descending limb of inner stripe of outer 
medulla of cortical nephron, 9B) LOH thin descending limb of inner stripe of outer medulla of 
juxtamedullary nephron, 10) upper LOH thin descending limb of inner medulla of juxtamedullary 
nephron, 11) lower LOH thin descending limb of inner medulla of juxtamedullary nephron, 12) lower 
LOH thin limb of inner medulla of juxtamedullary nephron, 13) lower LOH thin limb of inner medulla 
of juxtamedullary nephron, 14) upper LOH thin ascending limb of inner medulla of juxtamedullary 
nephron, 15) distal straight tubule of inner stripe of outer medulla (syn: thick ascending limb of LOH), 
16) distal straight tubule of outer stripe of outer medulla and cortex (syn: thick ascending limb of LOH), 
17) macula densa, 18) distal convoluted tubule, 19) nephron connecting tubule, 20) principal-like cell 
of nephron connecting tubule, 21) intercalated type non-A non-B cell of nephron connecting tubule, 
22) intercalated type A cell of nephron connecting tubule and cortical collecting duct, 23) principal-like 
cell of cortical collecting duct, 24) intercalated type B cell of cortical collecting duct, 25) intercalated 
type A cell of outer medullary collecting duct, 26) principal cell of outer medullary collecting duct, 27) 
intercalated type A cell of inner medullary collecting duct, 28) principal cell of inner medullary 
collecting duct type 1, 29) principal cell of inner medullary collecting duct type 2, 30) principal-like cell 
of deep inner medullary collecting duct type 1, 31) cell of deep inner medullary collecting duct type 2 
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and 32) deep medullary epithelium of pelvis. B) Expression of NaPi-IIa, NaPi-IIb, NaPi-IIc, Pit-1 and 
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A) NaPi-IIb B) NaPi-IIb, DAPI, actin
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